A case report of Hodgkin lymphoma in a patient treated with ustekinumab for psoriasis

RATIONALE: Ustekinumab is a biological agent that inhibits interleukin 12 and 23 and has been approved for the treatment of moderate and severe plaque psoriasis. There have been case reports that raise concerns about its oncogenic potential. We are the first authors to report a case of Hodgkin lymph...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Medicine (Baltimore)
Asıl Yazarlar: Charakopoulos, Emmanouil, Spyrou, Ioannis, Viniou, Nora-Athina, Giannakopoulou, Nefeli, Hatzidavid, Sevastianos, Diamantopoulos, Panagiotis Theodorou
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Wolters Kluwer Health 2020
Konular:
4800
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7249998/
https://ncbi.nlm.nih.gov/pubmed/32481271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000020048
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller